Business Description
BRAIN Biotech AG
ISIN : DE0005203947
Total Employee Number:
269Compare
Compare
Traded in other countries / regions
BNN.Germany0RFI.UK IPO Date
2017-12-11Description
BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.98 | |||||
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -1.24 | |||||
Debt-to-EBITDA | -1.27 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1.72 | |||||
Beneish M-Score | -2.45 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.3 | |||||
3-Year EBITDA Growth Rate | -53.9 | |||||
3-Year EPS without NRI Growth Rate | -12.4 | |||||
3-Year FCF Growth Rate | -12.8 | |||||
3-Year Book Growth Rate | -60.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.06 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.78 | |||||
9-Day RSI | 39.44 | |||||
14-Day RSI | 43.16 | |||||
3-1 Month Momentum % | 24.46 | |||||
6-1 Month Momentum % | 14.17 | |||||
12-1 Month Momentum % | 57.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.44 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 174.48 | |||||
Days Sales Outstanding | 59.24 | |||||
Days Payable | 86.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 3.42 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.4 | |||||
Operating Margin % | -14.03 | |||||
Net Margin % | -22.87 | |||||
EBITDA Margin % | -7.88 | |||||
FCF Margin % | -11.63 | |||||
OCF Margin % | -11.63 | |||||
ROE % | -668 | |||||
ROA % | -15.86 | |||||
ROIC % | -10.72 | |||||
3-Year ROIIC % | 8.58 | |||||
ROC (Joel Greenblatt) % | -35.11 | |||||
ROCE % | -16.65 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 88.33 | |||||
PS Ratio | 1.26 | |||||
EV-to-EBIT | -6.72 | |||||
EV-to-EBITDA | -15.61 | |||||
EV-to-Forward-EBITDA | 141.02 | |||||
EV-to-Revenue | 1.23 | |||||
EV-to-Forward-Revenue | 4.31 | |||||
EV-to-FCF | -11.4 | |||||
Price-to-GF-Value | 1.1 | |||||
Price-to-Median-PS-Value | 0.29 | |||||
Earnings Yield (Greenblatt) % | -14.88 | |||||
FCF Yield % | -9.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BRAIN Biotech AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 48.191 | ||
| EPS (TTM) (€) | -0.51 | ||
| Beta | 1.1247 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.02 | ||
| Volatility % | 57.67 | ||
| 14-Day RSI | 43.16 | ||
| 14-Day ATR (€) | 0.049188 | ||
| 20-Day SMA (€) | 2.804 | ||
| 12-1 Month Momentum % | 57.18 | ||
| 52-Week Range (€) | 1.825 - 3.59 | ||
| Shares Outstanding (Mil) | 21.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BRAIN Biotech AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BRAIN Biotech AG Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
BRAIN Biotech AG Frequently Asked Questions
What is BRAIN Biotech AG(HAM:BNN)'s stock price today?
The current price of HAM:BNN is €2.74. The 52 week high of HAM:BNN is €3.59 and 52 week low is €1.83.
When is next earnings date of BRAIN Biotech AG(HAM:BNN)?
The next earnings date of BRAIN Biotech AG(HAM:BNN) is .
Does BRAIN Biotech AG(HAM:BNN) pay dividends? If so, how much?
BRAIN Biotech AG(HAM:BNN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BRAIN Biotech AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers